Seung Mo Hong
(Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine)
,
Uiseob Lee
(Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine)
,
Sung-woo Kim
(Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine)
,
Youngmoon Goh
(Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine)
,
Min-Jae Park
(Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine)
,
Chiyoung Jeong
(Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine)
,
Jungwon Kwak
(Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine)
,
Byungchul Cho
(Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine)
Purpose: Although ionization chambers are widely used to measure beam commissioning data, point-by-point measurements of all the profiles with various field size and depths are time-consuming tasks. As an alternative, we investigated the feasibility of a linear diode array for commissioning a treatm...
Purpose: Although ionization chambers are widely used to measure beam commissioning data, point-by-point measurements of all the profiles with various field size and depths are time-consuming tasks. As an alternative, we investigated the feasibility of a linear diode array for commissioning a treatment planning system. Methods: The beam data of a Varian TrueBeam® radiotherapy system at 6 and 10 MV with/without a flattening filter were measured for commissioning of an Eclipse Analytical Anisotropic Algorithm (AAA) ver.15.6. All of the necessary beam data were measured using an IBA CC13 ionization chamber and validated against Varian "Golden Beam" data. After validation, the measured CC13 profiles were used for commissioning the Eclipse AAA (AAACC13). In addition, an IBA LDA-99SC linear diode array detector was used to measure all of the beam profiles and for commissioning a separate model (AAALDA99). Finally, the AAACC13 and AAALDA99 dose calculations for each of the 10 clinical plans were compared. Results: The agreement of the CC13 profiles with the Varian Golden Beam data was confirmed within 1% except in the penumbral region, where ≤2% of a discrepancy related to machine-specific jaw calibration was observed. Since the volume was larger for the CC13 chamber than for the LDA-99SC chamber, the penumbra widths were larger in the CC13 profiles, resulting in ≤5% differences. However, after beam modeling, the penumbral widths agreed within 0.1 mm. Finally the AAALDA99 and AAACC13 dose distributions agreed within 1% for all voxels inside the body for the 10 clinical plans. Conclusions: In conclusion, the LDA-99SC diode array detector was found to be accurate and efficient for measuring photon beam profiles to commission treatment planning systems.
Purpose: Although ionization chambers are widely used to measure beam commissioning data, point-by-point measurements of all the profiles with various field size and depths are time-consuming tasks. As an alternative, we investigated the feasibility of a linear diode array for commissioning a treatment planning system. Methods: The beam data of a Varian TrueBeam® radiotherapy system at 6 and 10 MV with/without a flattening filter were measured for commissioning of an Eclipse Analytical Anisotropic Algorithm (AAA) ver.15.6. All of the necessary beam data were measured using an IBA CC13 ionization chamber and validated against Varian "Golden Beam" data. After validation, the measured CC13 profiles were used for commissioning the Eclipse AAA (AAACC13). In addition, an IBA LDA-99SC linear diode array detector was used to measure all of the beam profiles and for commissioning a separate model (AAALDA99). Finally, the AAACC13 and AAALDA99 dose calculations for each of the 10 clinical plans were compared. Results: The agreement of the CC13 profiles with the Varian Golden Beam data was confirmed within 1% except in the penumbral region, where ≤2% of a discrepancy related to machine-specific jaw calibration was observed. Since the volume was larger for the CC13 chamber than for the LDA-99SC chamber, the penumbra widths were larger in the CC13 profiles, resulting in ≤5% differences. However, after beam modeling, the penumbral widths agreed within 0.1 mm. Finally the AAALDA99 and AAACC13 dose distributions agreed within 1% for all voxels inside the body for the 10 clinical plans. Conclusions: In conclusion, the LDA-99SC diode array detector was found to be accurate and efficient for measuring photon beam profiles to commission treatment planning systems.
Griessbach I, Lapp M, Bohsung J, Gademann G, Harder？D. Dosimetric characteristics of a new unshielded silicon？diode and its application in clinical photon and electron？beams. Med Phys. 2005;32:3750-3754.
Glide-Hurst C, Bellon M, Foster R, Altunbas C, Speiser M,？Altman M, et al. Commissioning of the Varian TrueBeam？linear accelerator: a multi-institutional study. Med Phys. 2013;40:031719.
Palmans H, Andreo P, Huq MS, Seuntjens J, Christaki KE,？Meghzifene A. Dosimetry of small static fields used in？external photon beam radiotherapy: summary of TRS-483, the IAEA-AAPM international Code of Practice for？reference and relative dose determination. Med Phys.？2018;45:e1123-e1145.
Barraclough B, Li JG, Lebron S, Fan Q, Liu C, Yan G. A novel？convolution-based approach to address ionization chamber volume averaging effect in model-based treatment？planning systems. Phys Med Biol. 2015;60:6213-6226.
AI-Helper
※ AI-Helper는 부적절한 답변을 할 수 있습니다.